At MediMix, we are dedicated to keeping Belgian healthcare professionals at the forefront of medicine. Our team brings you high-value insights from leading congresses worldwide, across key disease areas including oncology. In collaboration with Belgian and international experts, we transform the latest data into practical knowledge.
Latest publications
Dr Annalice Gandini and Dr Gertjan Rasschaert discuss the AGEO-NEO-MSI study, an international real-world cohort evaluating neoadjuvant immune checkpoint inhibition in non-metastatic dMMR/MSI colorectal cancer.
Prof Dr Eric Van Cutsem speaks with Dr Kohei Shitara about new strategies in HER2-positive metastatic oesophagogastric cancer.
Prof Dr Eric Van Cutsem speaks with Prof Dr Markus Moehler about the evolving role of immunotherapy in metastatic gastric and gastro-oesophageal junction cancer.
In this video, Dr Vittorio Studiale and Dr Gertjan Rasschaert discuss an individual patient data pooled analysis of five randomised clinical trials, presented at ESMO GI 2026 in Munich.
In this video, Dr Filip Van Herpe discusses two analyses from the phase III HERIZON-GEA-01 trial, presented at ESMO GI 2026 in Munich.
At MediMix, we are dedicated to keeping Belgian healthcare professionals at the forefront of medicine. Our team brings you high-value insights from leading congresses worldwide, across key disease areas including oncology. In collaboration with Belgian and international experts, we transform the latest data into practical knowledge.
Latest publications
Dr Annalice Gandini and Dr Gertjan Rasschaert discuss the AGEO-NEO-MSI study, an international real-world cohort evaluating neoadjuvant immune checkpoint inhibition in non-metastatic dMMR/MSI colorectal cancer.
Prof Dr Eric Van Cutsem speaks with Dr Kohei Shitara about new strategies in HER2-positive metastatic oesophagogastric cancer.
Prof Dr Eric Van Cutsem speaks with Prof Dr Markus Moehler about the evolving role of immunotherapy in metastatic gastric and gastro-oesophageal junction cancer.
In this video, Dr Vittorio Studiale and Dr Gertjan Rasschaert discuss an individual patient data pooled analysis of five randomised clinical trials, presented at ESMO GI 2026 in Munich.
In this video, Dr Filip Van Herpe discusses two analyses from the phase III HERIZON-GEA-01 trial, presented at ESMO GI 2026 in Munich.
